Abstract:Background and aim Obesity is becoming a major global health concern, as it is associated with many diseases, such as Non‐Alcoholic Fatty Liver Disease (NAFLD). NAFLD is associated with diabetes, metabolic syndrome and, and is known to be multifactorial. Meaning that it is affected by multiple external and environmental factors. The progression of NAFLD to Non‐alcoholic Steatohepatitis (NASH), liver carcinoma and further to liver failure, makes it very crucial that we pay attention to the disease at its earlier stages. Further, NAFLD is affected by the circadian rhythm, which is a 24‐hour cycle that controls biological activities of all cells. In the liver, this rhythmic cycle is called liver clock and is very sensitive to nutritional intake, physical activity and sleeping patterns, and it is controlled by Clock genes. The expression of clock genes can be controlled by DNA methylation, which is a modification that acts as a switch to turn genes on and off. Therefore, this study aimed to study the methylation status of clock genes and clock‐controlled genes at the promoter region. Methods C57BL/6 mice were treated with high‐fat diet (HFD) or control (CTR) for 8 wk. Mouse livers were harvested for further analysis. Liver function was evaluated by serum chemistry, fibrosis was measured by IHC and PCR and lipid deposition were evaluated by Oil red O staining. Genomic DNA and total RNA were obtained for measuring the DNA methylation of core clock genes and RNA expression as described above. Methylation‐Specific PCR (MSP) and Sanger sequencing were used to evaluate the change in the gene expression of genes of interest; CLOCK, BMAL‐1 and PPAR‐a in a high‐fat diet group and control‐diet group. Results We found increased steatosis and hepatic fibrosis in mice fed a high‐fat diet compared to control. Expression of fibrotic markers (a‐SMA, FN1 and collagen I) was upregulated in mice fed high‐fat diet compared to control. Differential DNA methylation status in promoter regions was observed in different core clock genes in high‐fat‐fed mice. Conclusion DNA methylation of core clock genes and clock‐controlled genes may lead to dysregulation of the circadian rhythm during consumption of a high fat diet, thus leading to increased steatosis and liver fibrosis.

Whole-genome DNA Methylation and Gene Expression Profiling in the Livers of Mice with Nonalcoholic Steatohepatitis.

Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease

Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)

Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis

Proteomic Analysis of Liver Mitochondria from Rats with Nonalcoholic Steatohepatitis

Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH

Coordinated Changes of Gut Microbiome and Lipidome Differentiates Nonalcoholic Steatohepatitis (NASH) from Isolated Steatosis.

DNA Methylation of SMPD3-based Diagnostic Biomarkers of NASH and Mild Fibrosis.

A Multi-Omic Landscape of Steatosis-to-nash Progression

Genome-Wide Analysis Of Dna Methylation In Human Peripheral Leukocytes Identifies Potential Biomarkers Of Nonalcoholic Fatty Liver Disease

Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation

Analysis of diet-induced differential methylation, expression, and interactions of lncRNA and protein-coding genes in mouse liver

ROLE OF DNA METHYLAION IN THE PROMOTER REGION OF CLOCK GENES IN THE REGULATION OF LIVER DISEASE

Microanatomy of the metabolic associated fatty liver disease (MAFLD) by single-cell transcriptomics

Identification of Hub Genes Associated with Non-alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease

Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD

Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease

A mouse model of nonalcoholic steatohepatitis induced by feeding a methionine-choline-deficient diet: establishment and dynamic monitoring

Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease

Promotion of Nonalcoholic Steatohepatitis by RNA N6-methyladenosine Reader IGF2BP2 in Mice